Ki-67, Immunohistochemistry (IHC)
Ki67 is a protein that is present during all active phases of cell division. Ki67 analysis is typically used to evaluate tumor cells that are positive for the protein in order to determine the aggressiveness of the cancer. Prostate and breast cancer are the two most common cancers for which the Ki67 protein is evaluated. In evaluating breast cancer tumor cells, a high percentage of Ki67-positive tumor cells are associated with aggressive cancer and predictive of poor prognosis. High Ki67 results are also predictive of recurrence. The high Ki67 score indicates that the cells are rapidly growing and dividing.
Ki67 results can be useful to target chemotherapy to these aggressive tumors. Ki67 is also used as a biomarker for patients with prostate cancer. Typically prostate cancer cells grow slowly. Prostate cancer cells that have a high Ki67 score are more aggressive and may show a predictive value for recurrence. Treatment can also be targeted to Ki67 positive tumor cells in prostate cancer patients.
- Is used as an indicator of cell proliferation to support neoplastic (cancer) findings in IHC along with other tumor markers
- Is used to determine the percentage of positive tumor cells using a paraffin-embedded tissue block
- Results will be reported as a percentage of cells staining positive for MIB-1. Results should be interpreted within the clinical context for which the test was ordered
Varies by tumor type; values reported from 0% to 100%.
Formalin-fixed, paraffin-embedded (FFPE) tissue block containing breast or prostate carcinoma.
tissues in FFPE are stable in room temperature for longer.
- Lancet Oncol. 2010 Feb;11(2):174-83. [PMID: 20152769]
- J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64. [PMID: 21960707]
- J Cell Physiol. 2000 Mar;182(3):311-22. [PMID: 10653597]
- Semin Cancer Biol. 1990 Jun;1(3):199-206. [PMID: 2103495]
- Am J Clin Pathol. 1991 Oct;96(4):444-6. [PMID: 1716412]